Thrombophilia epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing. {{Thrombophilia}} {{CMG}} ==Overview=..." |
No edit summary |
||
Line 5: | Line 5: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
==Epidemiology and Demographics== | |||
===Prevalence of various inherited thrombophilias and their clinical impact=== | |||
{| border="1" cellpadding="5" cellspacing="0" align="center" class="sortable" | |||
|- | |||
! Disorder | |||
! Healthy subjects/General population (%) | |||
! Patients with known thrombosis (%) | |||
! Estimated increase in thrombosis risk | |||
|- | |||
| [[Antithrombin deficiency]] | |||
| 0.02 | |||
| 1 - 4 | |||
| 10 - 20X | |||
|- | |||
| [[Dysfibrinogenemia]] | |||
| <1 | |||
| <1 | |||
| Variable | |||
|- | |||
| [[Protein C deficiency]] | |||
| 0.2 - 0.4 | |||
| 3 - 5 | |||
| 10X | |||
|- | |||
| [[Protein S deficiency]] | |||
| 0.3 - 0.13 | |||
| 2 - 4 | |||
| 10X | |||
|- | |||
| [[Factor V Leiden]] | |||
| 1 - 15 | |||
| 18 - 40 | |||
| 5X | |||
|- | |||
| G20210A [[prothrombin]] gene mutation | |||
| 2 - 5 | |||
| 7 - 16 | |||
| 3X | |||
|- | |||
| [[Hyperhomocystenemia]] | |||
| 5 | |||
| 10 | |||
| 3X | |||
|- | |||
| Elevated [[factor VIII]] levels | |||
| 11 | |||
| 25 | |||
| 5X | |||
|- | |||
|} | |||
The table has been adapted from Best Pract Res Clin Obstet Gynaecol. 2003 Jun;17(3):397-411<ref name="pmid12787534">{{cite journal |author=Buchanan GS, Rodgers GM, Ware Branch D |title=The inherited thrombophilias: genetics, epidemiology, and laboratory evaluation |journal=Best Pract Res Clin Obstet Gynaecol |volume=17 |issue=3 |pages=397–411 |year=2003 |month=June |pmid=12787534 |doi= |url=}}</ref> and data has been obtained from references<ref name="pmid11309638">{{cite journal |author=Seligsohn U, Lubetsky A|title=Genetic susceptibility to venous thrombosis |journal=N. Engl. J. Med. |volume=344 |issue=16 |pages=1222–31 |year=2001 |month=April |pmid=11309638|doi=10.1056/NEJM200104193441607 |url=}}</ref><ref name="pmid11702218">{{cite journal |author=Franco RF, Reitsma PH |title=Genetic risk factors of venous thrombosis |journal=Hum. Genet. |volume=109 |issue=4 |pages=369–84 |year=2001 |month=October |pmid=11702218 |doi=10.1007/s004390100593 |url=}}</ref><ref name="pmid7740487">{{cite journal |author=Haverkate F, Samama M |title=Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen |journal=Thromb. Haemost. |volume=73 |issue=1 |pages=151–61 |year=1995 |month=January |pmid=7740487 |doi= |url=}}</ref>. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 13:22, 21 September 2012
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Thrombophilia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Thrombophilia epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Thrombophilia epidemiology and demographics |
Risk calculators and risk factors for Thrombophilia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
Prevalence of various inherited thrombophilias and their clinical impact
Disorder | Healthy subjects/General population (%) | Patients with known thrombosis (%) | Estimated increase in thrombosis risk |
---|---|---|---|
Antithrombin deficiency | 0.02 | 1 - 4 | 10 - 20X |
Dysfibrinogenemia | <1 | <1 | Variable |
Protein C deficiency | 0.2 - 0.4 | 3 - 5 | 10X |
Protein S deficiency | 0.3 - 0.13 | 2 - 4 | 10X |
Factor V Leiden | 1 - 15 | 18 - 40 | 5X |
G20210A prothrombin gene mutation | 2 - 5 | 7 - 16 | 3X |
Hyperhomocystenemia | 5 | 10 | 3X |
Elevated factor VIII levels | 11 | 25 | 5X |
The table has been adapted from Best Pract Res Clin Obstet Gynaecol. 2003 Jun;17(3):397-411[1] and data has been obtained from references[2][3][4].
References
- ↑ Buchanan GS, Rodgers GM, Ware Branch D (2003). "The inherited thrombophilias: genetics, epidemiology, and laboratory evaluation". Best Pract Res Clin Obstet Gynaecol. 17 (3): 397–411. PMID 12787534. Unknown parameter
|month=
ignored (help) - ↑ Seligsohn U, Lubetsky A (2001). "Genetic susceptibility to venous thrombosis". N. Engl. J. Med. 344 (16): 1222–31. doi:10.1056/NEJM200104193441607. PMID 11309638. Unknown parameter
|month=
ignored (help) - ↑ Franco RF, Reitsma PH (2001). "Genetic risk factors of venous thrombosis". Hum. Genet. 109 (4): 369–84. doi:10.1007/s004390100593. PMID 11702218. Unknown parameter
|month=
ignored (help) - ↑ Haverkate F, Samama M (1995). "Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen". Thromb. Haemost. 73 (1): 151–61. PMID 7740487. Unknown parameter
|month=
ignored (help)